SCHEMBL23791003

SCHEMBL23791003

C=C(CCC(C)C1CCC2(C)C3CCC4C(C)(C)C(OC(=O)/C=C/c5ccccc5)CCC45CC35CCC12C)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ HSD11B1 P28845 7/20 0.50
▸ ACLY P53396 2/20 0.44
▸ ACACA Q13085 2/20 0.44
▸ CYP2C19 P33261 1/20 0.43
▸ PTPN11 Q06124 1/20 0.42
▸ PTPN2 P17706 1/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ ACP1 P24666 1/20 0.40
▸ HSD11B2 P80365 2/20 0.40
▸ IKBKB O14920 2/20 0.38
▸ SLC10A1 Q14973 1/20 0.38
▸ RELA Q04206 1/20 0.37
▸ NR3C1 P04150 1/20 0.35
▸ NR3C2 P08235 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23780405 0.90 MEN1 (0.49) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL6438953 0.88 MEN1 (0.76) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL23484310 0.88 MEN1 (0.76) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL13420339 0.88 HSD11B1 (0.53) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL10017449 0.87 MEN1 (0.63) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL23791024 0.87 ACLY (0.57) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL14046876 0.84 HSD11B1 (0.54) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL13420642 0.84 HSD11B1 (0.54) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL13420433 0.84 HSD11B1 (0.54) MEN1KMT2AHSD11B1ACLYACACA
SCHEMBL10349531 0.81 MEN1 (0.48) MEN1KMT2AHSD11B1ACLYACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275939-A1 MARSDENIA CUNDURANGO CREEPER EXTRACTS, COSMETIC COMPOSITIONS COMPRISING THEM AND COSMETIC USES OF SAME ISP INVESTMENTS LLC (US) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275939-A1 MARSDENIA CUNDURANGO CREEPER EXTRACTS, COSMETIC COMPOSITIONS COMPRISING THEM AND COSMETIC USES OF SAME CUTA, TYR, TPSD1 MEN1 1248/4885KMT2A 4611/4885HSD11B1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback